Table 4.
Median levels of T cell intracellular DAMPs (defensing beta 2 (DEFβ2), heat shock 27 kDa protein 1 (Hsp27), thioredoxin (Trx)) and extracellular DAMPs (fibronectin (Fn), hyaluronan (HA), high mobility group protein 1 (HMG1), uric acid (UA)) in studied participants’ blood samples.
| Variable | YYRL1 Group (N = 10) |
Beep Group (N = 10) |
MT Group (N = 10) |
pKW | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | ||
| Median (Minimum–Maximum) | Median (Minimum–Maximum) | Median (Minimum–Maximum) | |||||||||||
| DEF2 (pg/mL) | 26.8 (10.8–30.0) |
15.2 (10.8–29.8) |
15.4 (10.9–29.8) |
0.182 | 30.0 (10.1–44.3)A |
58.9 (33.8–75.4) |
57.0 (11.4–80.1) |
0.032 | 30.8 (25.4–41.9) |
25.9 (18.0–39.5) |
24.0 (14.6–45.7) |
0.061 | 0.077 |
| ratio | 0.8 (0.0–1.0) |
0.7 (0.4–1.7) |
1.7 (1.2–5.8) |
1.9 (0.3–8.0) |
0.8 (0.6–1.0) |
0.7 (0.4–1.5) |
<0.001 0.097 |
||||||
| Hsp27 (ng/mL) | 3.2 (2.4–4.7)A |
4.1 (3.3–5.9)B |
3.8 (2.4–4.9) |
0.007 | 3.0 (2.2–4.3)A |
3.7 (3.0–6.2)B |
3.0 (1.6–4.4) |
0.007 | 3.4 (2.7–4.0) |
3.4 (2.1–4.5) |
3.5 (2.8–4.5) |
0.272 | 0.509 |
| ratio | 1.4 (1.0–1.9) |
1.0 (0.8–2.1) |
1.2 (0.9–2.5) |
0.9 (0.5–1.9) |
1.0 (0.6–1.2) |
1.1 (0.8–1.4) |
0.019 0.335 |
||||||
| Trx (ng/mL) | 21.3 (15.4–29.0) |
25.1 (13.5–54.4) |
28.2 (15.9–44.6) |
0.082 | 30.3 (9.2–70.1) |
17.4 (7.1–55.3) |
26.3 (5.2–54.7) |
0.272 | 10.6 (3.7–48.3) |
15.9 (2.6–40.1) |
21.8 (6.0–30.3) |
0.670 | 0.034 |
| ratio | 1.1 (1.0–2.3) |
1.5 (0.7–1.7) |
0.7 (0.4–2.6) |
0.7 (0.3–3.0) |
1.7 (0.5–3.6) |
1.8 (0.2–8.1) |
0.071 0.164 |
||||||
| Fn (mg/mL) | 0.18 (0.16–0.22) |
0.18 (0.06–0.23) |
0.19 (0.11–0.22) |
0.496 | 0.14 (0.06–0.35)A |
0.21 (0.16–0.40) |
0.22 (0.11–0.37)C |
0.002 | 0.17 (0.05–0.38) |
0.18 (0.05–0.33) |
0.19 (0.09–0.36) |
0.497 | 0.187 |
| ratio | 1.0 (0.0–1.2) |
1.0 (0.6–1.2) |
1.4 (1.1–3.9) |
1.5 (0.6–4.0) |
1.0 (0.6–1.3) |
1.1 (0.7–2.5) |
<0.001 0.017 |
||||||
| HA (ng/mL) | 19.3 (7.3–26.6)A |
46.7 (23.2–59.3)B |
18.6 (10.0–25.9) |
< 0.001 | 12.4 (6.7–22.5) |
23.9 (16.8–144.0) |
12.3 (1.6–32.4) |
0.061 | 17.3 (1.9–28.4) |
18.4 (1.5–89.7) |
24.7 (5.4–65.2) |
0.150 | 0.284 |
| ratio | 2.7 (1.0–7.2) |
1.0 (0.5–4.7) |
1.8 (0.9–21.5) |
1.2 (0.1–1.7) |
1.0 (0.4–4.2) |
1.9 (0.4–3.5) |
0.122 0.083 |
||||||
| HMG1 (ng/mL) | 2.4 (1.2–4.1) |
3.2 (1.5–9.4) |
3.5 (1.1–8.4) |
0.496 | 2.5 (1.9–3.0) |
3.3 (2.3–10.7) |
2.3 (1.4–9.6) |
0.061 | 4.5 (3.5–5.0) |
4.4 (3.7–5.6) |
4.6 (2.9–8.4) |
0.741 | <0.001 |
| ratio | 1.3 (1.0–3.7) |
1.4 (0.5–4.7) |
1.4 (0.9–3.9) |
1.0 (0.6–3.5) |
1.0 (0.8–1.5) |
1.1 (0.6–2.1) |
0.074 0.903 |
||||||
| UA (µmol/L) | 261 (145–373) |
282 (152–393) |
289 (138–347) |
0.067 | 345 (219–552)A |
388 (278–571) |
347 (210–527) |
0.014 | 307 (241–383) |
333 (211–392) |
356 (260–402) |
0.061 | 0.024 |
| ratio | 1.1 (1.0–1.3) |
1.0 (0.8–1.2) |
1.1 (1.0–1.3) |
1.0 (0.6–1.6) |
1.1 (0.9–1.2) |
1.1 (0.9–1.4) |
0.196 0.346 |
||||||